Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle
HAMILTON, A. L, EDER, J. P, KINCHLA, N, BOYDEN, J, YEE, H, ZELENIUCH-JACQUOTTE, A, WRIGHT, J, ELLIOTT, P, ADAMS, J, MUGGIA, F. M, PAVLICK, A. C, CLARK, J. W, LIEBES, L, GARCIA-CARBONERO, R, CHACHOUA, A, RYAN, D. P, SOMA, V, FARRELL, K
Published in Journal of clinical oncology (01.09.2005)
Published in Journal of clinical oncology (01.09.2005)
Get full text
Journal Article
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
Hui, R., Garon, E.B., Goldman, J.W., Leighl, N.B., Hellmann, M.D., Patnaik, A., Gandhi, L., Eder, J.P., Ahn, M.-J., Horn, L., Felip, E., Carcereny, E., Rangwala, R., Lubiniecki, G.M., Zhang, J., Emancipator, K., Roach, C., Rizvi, N.A.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
Antman, K, Ayash, L, Elias, A, Wheeler, C, Hunt, M, Eder, J P, Teicher, B A, Critchlow, J, Bibbo, J, Schnipper, L E
Published in Journal of clinical oncology (01.01.1992)
Published in Journal of clinical oncology (01.01.1992)
Get more information
Journal Article
First-in-human study of the monopolar spindle 1 (Mps1) kinase inhibitor BAY 1161909 in combination with paclitaxel in subjects with advanced malignancies
Lorusso, P, Chawla, S P, Bendell, J, Shields, A F, Shapiro, G, Rajagopalan, P, Cyris, C, Bruns, I, Mei, J, Souza, F, Rasco, D, Eder, J P, Tolcher, A W
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response
Ayash, L J, Wright, J E, Tretyakov, O, Gonin, R, Elias, A, Wheeler, C, Eder, J P, Rosowsky, A, Antman, K, Frei, 3rd, E
Published in Journal of clinical oncology (01.06.1992)
Published in Journal of clinical oncology (01.06.1992)
Get more information
Journal Article
Automatic Personalisation of Study Guides in Flipped Classroom: A Case Study in a Distributed Systems Course
Araujo, Pedro, Costa, Cecilia, Viana, Windson, de Lima Veras, Necio, Farias, Eder J. P.
Published in 2020 IEEE Frontiers in Education Conference (FIE) (21.10.2020)
Published in 2020 IEEE Frontiers in Education Conference (FIE) (21.10.2020)
Get full text
Conference Proceeding
A phase I clinical trial of continual alternating etoposide and topotecan in refractory solid tumours
PENSON, R. T, SEIDEN, M. V, MATULONIS, U. A, APPLEMAN, L. J, FULLER, A. F, GOODMAN, A, CAMPOS, S. M, CLARK, J. W, ROCHE, M, EDER, J. P
Published in British journal of cancer (11.07.2005)
Published in British journal of cancer (11.07.2005)
Get full text
Journal Article
A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support
Shea, T C, Flaherty, M, Elias, A, Eder, J P, Antman, K, Begg, C, Schnipper, L, Frei, 3rd, E, Henner, W D
Published in Journal of clinical oncology (01.05.1989)
Published in Journal of clinical oncology (01.05.1989)
Get more information
Journal Article
DNA topoisomerase II α expression is associated with alkylating agent resistance
EDER, J. P, CHAN, V. T.-W, SHU-WING NG, NAIYER, N. A, ZACHAROULIS, S, TEICHER, B. A, SCHNIPPER, L. E
Published in Cancer research (Chicago, Ill.) (15.12.1995)
Get full text
Published in Cancer research (Chicago, Ill.) (15.12.1995)
Journal Article
Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion
J P Eder, Jr, J G Supko, T Lynch, M Bryant, E Vosburgh, L N Shulman, G Xu, D W Kufe
Published in Clinical cancer research (01.02.1998)
Get full text
Published in Clinical cancer research (01.02.1998)
Journal Article
A Two-Step Method to Covalently Bind Biomolecules to Group-IV Semiconductors: Si(111)/1,2-Epoxy-9-decene/Esterase
Jeanquartier, Claire, Schider, Gerburg, Feichtenhofer, Sabine, Schwab, Helmut, Schennach, Robert, Stettner, Johanna, Winkler, Adolf, Gruber-Woelfler, Heidrun, Schitter, Georg, Eder, Rafael J. P, Khinast, Johannes G
Published in Langmuir (16.12.2008)
Published in Langmuir (16.12.2008)
Get full text
Journal Article
Continuously Seeded, Continuously Operated Tubular Crystallizer for the Production of Active Pharmaceutical Ingredients
Eder, Rafael J. P, Radl, Stefan, Schmitt, Elisabeth, Innerhofer, Sabine, Maier, Markus, Gruber-Woelfler, Heidrun, Khinast, Johannes G
Published in Crystal growth & design (05.05.2010)
Published in Crystal growth & design (05.05.2010)
Get full text
Journal Article
Phase I and Pharmacokinetic Study of LU79553, a DNA Intercalating Bisnaphthalimide, in Patients With Solid Malignancies
VILLALONA-CALERO, Miguel A, EDER, Joseph P, KUFE, Donald W, VON HOFF, Daniel D, ROWINSKY, Eric K, TOPPMEYER, Deborah L, ALLEN, Lee F, FRAM, Robert, VELAGAPUDI, Raja, MYERS, Michael, AMATO, Anthony, KAGEN-HALLET, Kathleen, RAZVILLAS, Betty
Published in Journal of clinical oncology (01.02.2001)
Published in Journal of clinical oncology (01.02.2001)
Get full text
Journal Article
Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide
Wheeler, C, Strawderman, M, Ayash, L, Churchill, W H, Bierer, B E, Elias, A, Gilliland, D G, Antman, K, Guinan, E C, Eder, J P
Published in Journal of clinical oncology (01.06.1993)
Published in Journal of clinical oncology (01.06.1993)
Get more information
Journal Article
Intensive combined modality therapy for limited-stage small-cell lung cancer
Elias, A D, Ayash, L, Frei, 3rd, E, Skarin, A T, Hunt, M, Wheeler, C, Schwartz, G, Mazanet, R, Tepler, I, Eder, J P
Published in JNCI : Journal of the National Cancer Institute (07.04.1993)
Published in JNCI : Journal of the National Cancer Institute (07.04.1993)
Get more information
Journal Article
Sequence effect of irinotecan (CPT-11) and topoisomerase II inhibitors in vivo
EDER, J. P, CHAN, V, WONG, J, WONG, Y. W, ARA, G, NORTHEY, D, RIZVI, N, TEICHER, B. A
Published in Cancer chemotherapy and pharmacology (1998)
Published in Cancer chemotherapy and pharmacology (1998)
Get full text
Journal Article